$77.9 Million is the total value of New Leaf Venture Partners, L.L.C.'s 12 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 14.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARVN | ARVINAS INC | $25,390,668 | -20.7% | 1,289,521 | 0.0% | 32.60% | +18.6% | |
| DCPH | DECIPHERA PHARMACEUTICALS INC | $15,385,743 | -9.7% | 1,209,571 | 0.0% | 19.76% | +35.1% | |
| RALLYBIO CORPORATION | $11,126,402 | -40.5% | 3,301,603 | 0.0% | 14.29% | -11.0% | ||
| EWTX | EDGEWISE THERAPEUTICS INC | $8,902,478 | -26.1% | 1,553,661 | 0.0% | 11.43% | +10.6% | |
| COGT | COGENT BIOSCIENCES INC. | $4,889,918 | -17.7% | 501,530 | 0.0% | 6.28% | +23.1% | |
| CRNX | CRINETICS PHARMACEUTICALS INC | $4,193,340 | +65.0% | 141,000 | 0.0% | 5.38% | +146.8% | |
| RCKT | ROCKET PHARMACEUTICALS INC | $2,422,779 | +3.1% | 118,242 | 0.0% | 3.11% | +54.2% | |
| ALEC | ALECTOR INC | $2,200,407 | +7.8% | 339,569 | 0.0% | 2.83% | +61.2% | |
| PASG | PASSAGE BIO | $1,648,629 | -29.8% | 2,497,922 | 0.0% | 2.12% | +5.0% | |
| HARP | Sell | HARPOON THERAPEUTICS INC | $1,272,142 | -43.2% | 315,668 | -90.0% | 1.63% | -15.1% |
| XFOR | X4 PHARMACEUTICALS INC | $365,150 | -43.8% | 335,000 | 0.0% | 0.47% | -15.9% | |
| ITERUM THERAPEUTICS PLC | $77,667 | -25.2% | 97,084 | 0.0% | 0.10% | +12.4% | ||
| ARAV | Exit | ARAVIVE INC | $0 | – | -946,423 | -100.0% | -1.02% | – |
| Exit | DICE THERAPEUTICS INC | $0 | – | -371,693 | -100.0% | -14.83% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DECIPHERA THERAPEUTICS INC | 25 | Q3 2023 | 44.4% |
| CHIMERIX INC | 25 | Q1 2023 | 20.9% |
| SIERRA ONCOLOGY INC | 22 | Q2 2022 | 14.9% |
| ARVINAS INC | 21 | Q3 2023 | 44.8% |
| CRINETICS PHARMACEUTICALS INC | 21 | Q3 2023 | 11.4% |
| OBSEVA SA | 20 | Q4 2021 | 8.5% |
| AVROBIO INC | 20 | Q1 2023 | 1.7% |
| HARPOON THERAPEUTICS INC | 19 | Q3 2023 | 20.0% |
| ALECTOR INC | 19 | Q3 2023 | 4.6% |
| ITERUM THERAPEUTICS PLC | 18 | Q3 2022 | 3.8% |
View New Leaf Venture Partners, L.L.C.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-06 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-09 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
View New Leaf Venture Partners, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.